Abbott Laboratories is under fresh scrutiny as price targets are reset, with some analysts trimming their expectations and ...
Abbott Laboratories (ABT) is back in focus after mixed first quarter results, a cut to its 2026 adjusted EPS outlook tied to ...
Abbott Labs Medical Devices and Diagnostics segments drive robust growth, with the Exact Sciences acquisition adding value.
A Missouri appellate court has upheld a $495 million verdict against Abbott Laboratories in a case over whether its formula ...
Abbott Laboratories trades at 17.7x forward earnings, the lowest valuation multiple in a decade. Read why I rate ABT stock a ...
Abbott Laboratories must pay $53 million in compensatory damages in four cases in which Chicago area babies developed a ...
It essentially met analyst expectations for its inaugural quarter of 2026.
Zacks Investment Research on MSN
Abbott Laboratories (ABT) is a trending stock: Facts to know before betting on it
Abbott (ABT) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...
View Abbott Laboratories ABT stock quote prices, financial information, real-time forecasts, and company news from CNN.
Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...
Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Abbott Laboratories has petitioned the Internal Revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results